FDA 483 - Louisville Reproductive Center - April 08, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
The FDA inspection of Louisville Reproductive Center identified critical failures in donor screening and eligibility determination for human cells, tissues, and cellular and tissue-based products (HCT/Ps). The firm failed to properly screen donors for communicable diseases, including determining ineligibility for reactive donors and conducting complete screenings. Significant deficiencies were also noted in donor record-keeping and the establishment of adequate testing procedures.
- Person
ID · 872e14d0-2745-42ba-a15d-d08db1d00f46